Abstract Claims Description Full Text

Abstract

A method of producing antibodies comprising the step of encoding a peptide sequence from a Domain I perlecan splice variant, wherein the peptide sequence is used to produce anti-peptide antibodies.

Other References

• Ailles, et al., “Induction of Perlecan Gene Expression Precedes Amyloid Formation During Experimental Murine AA Amyloidogenesis,” Laboratory Investigation, vol. 69, No. 4, pp. 443-448, 1993.
• Cohen et al., “Structural Characterization of the Complete Human Perlecan Gene and its Promoter,” Proc. Natl. Acad. Sci USA, vol. 90, pp. 10404-10408, 1993.
• Dolan et al., “Identification and Sites in Domain I of Perlecan That Regulate Heparan Sulfate Synthesis,” Journal of Bio. Chem, vol. 272, No. 7, pp. 4316-4322, Feb. 14, 1997.
• Groffen, et al., “Expression and Characterization of Human Perlecan Domains I and II Synthesized by Baculovirus-infected Insect Cells,” European Journal of Biochem., vol. 241, pp. 827-834, 1996.
• Murdoch et al., “Widespread Expression of Perlecan Proteoglycan in Basement Membranes and Extracellular Matrices of Human Tissues as Detected by a Novel Monoclonal Antibody Against Domain III and by In Situ Hybridization,” The Journal of Histochem. and Cytochem., vol. 42, No. 2, pp. 239-249, 1994.
• Noonan et al., “Perlecan, the Large Low-density Proteoglycan of Basement Membranes: Structure and Variant Forms,” Kidney International, vol. 43, pp. 53-60, 1993.
• Sigma Chemical Company, “Biochemicals Organic Compounds for Research and Diagnostic Reagents,” Sigma Chemical Company, 1992, pp. 513 (see products entitle heparan sulfate).
• Stryer, Biochemsity, W.H. Freeman and Company, San Francisco, 1981, pp. 13-16 and 512-513.
• Goedert et al., “Assembly of Microtubule-associated Protein Tau into Alzheimer-life Filaments Induced by Sulphated Glycosaminoglycans,” Nature, vol. 383, pp. 550-553, Oct. 1996.
• Maresh et al., “Detection and Quantitation of Perlecan mRNA Levels in Alzheimer's Disease and Normal Aged Hippocampus by Competitive Reverse Transcription-Polymerase Chain Reaction,” J. Neurochem., vol. 67, No. 3, pp. 1132-1143, 1996.
• Murdoch et al., “Primary Structure of the Human Heparan Sulfate Proteoglycan from Basement Membrane (HSPG2/Perlecan),” Journal of Bio. Chem., vol. 267, No. 12, pp. 8544-8557, Apr. 25, 1992.
• Snow et al., “The Presence of Heparan Sulfate Proteoglycans in the Neuritic Plaques and Congophilic Angiopathy in Alzheimer's Disease,” American Journal of Pathology, vol. 133, No. 3, pp. 456-463, Dec. 1988.
• Snow et al., “Immunolocalization of Heparan Sulfate Proteoglycans to the Prion Protein Amyloid Plaques of Gerstmann-Straussler Syndrome, Creutzfeldt-Jakob Disease and Scrapie,”Laboratory Investigation, vol. 63, No. 5, pp. 601-611, 1990.
• Snow et al., “Proteoglycans in the Pathogenesis of Alzheimer's Disease and Other Amyloidoses,” Neurobiology of Aging, vol. 10, pp. 481-497, 1989.
• Snow et al., “Heparan Sulfate Proteoglycans in Diffuse Plaques of Hippocampus but not of Cerebellum in Alzheimer's Disease Brain,” American Journal of Pathology, vol. 144, No. 2, pp. 337-347, Feb. 1994.
• Snow et al., “Differential Binding of Vascular Cell-Derived Proteoglycans (Perlecan, Biglycan, Decorin, and Versican) to the Beta-Amyloid Protein of Alzheimer's Disease,” Archives of Biochemistry and Biophysics, vol. 320, No. 1, pp. 84-95, Jun. 20, 1995.
• Brunden et al., “pH-Dependent Binding of Synthetic β-Amyloid Peptides in Glycosaminoglycans,” J. Neurochem., vol. 61, No. 6, pp. 2147-2154, 1993.
• Snow et al., “An Important Role of Heparan Sulfate Proteoglycan (Perlecan) in a Model System for the Deposition and Persistence of Fibrillar Aβ-Amyloid in Rat Brain,” Neuron, vol. 12, pp. 219-234, Jan. 1994.
• Gupta-Bansal et al., “Proteoglycan-Mediated Inhibition of Aβ Proteolysis,” Journal of Bio. Chem., vol. 270, No. 31, pp. 18666-18671, 1995.
• Snow et al., “Early Accumulation of Heparan Sulfate in Neurons and in the Beta-Amyloid Protein-Containing Lesions of Alzheimer's Disease and Down's Syndrome,” American Journal of Pathology, vol. 137, No. 5, pp. 1253-1270, Nov. 1990.
• Kallunki et al., “Human Basement Membrane Heparan Sulfate Proteoglycan Core Protein: A 467-kD Protein Containing Multiple Domains Resembling Elements of the Low Density Lipoprotein Receptor, Laminin, Neural Cell Adhesion Molecules, and Epidermal Growth Factor,” Journal of Cell Biology, vol. 116, pp. 559-571, 1992.
• Noonan et al., “The Complete Sequence of Perlecan, a Basement Membrane Heparan Sulphate Proteoglycan, Reveals Extensive Similarity with Laminin A Chain, Low Density Lipoprotein-Receptor, and the Neural Cell Adhesion Molecule,” Journal of Bio. Chem., vol. 266, No. 34, pp. 22939-22947, Dec. 5, 1991.
• Kato et al., “Basement Membrane Proteoglycan in Various Tissues: Characterization Using Monoclonal Antibodies to the Engelbreth-Holm-Swarm Mouse Tumor Low Density Heparan Sulfate Proteoglycan,” Journal of Cell Biology, pp. 2203-2210, Jun. 1988.
• Kokenyesi et al., “Formation of Heparan Sulfate or Chondroitin/Dermatan Sulfate on Recombinant Domain I of Mouse Perlecan Expressed in Chinese Hamster Ovary Cells,” Biochemical and Biophysical Research Communications, vol. 211, No. 1, pp. 262-267, Jun. 6, 1995.
• Nochlin et al., “A Simple Method of Rapid Freezing Adequately Preserves Brain Tissue for Immunocytochemistry Light and Electron Microscopic Examination,” Acta Neuropathol, vol. 86, pp. 645-650, 1993.
• Jacob et al., “The 5′Splice Site: Phylogenetic Evolution and Variable Geometry of Association with U1RNA,” Nucleic Acids Research, vol. 17, No. 6, pp. 2159-2180, 1989.
• Jackson et al., “A Reappraisal of Non-Consensus mRNA Splice Sites,” Nucleic Acids Research, vol. 19, No. 14, pp. 3795-3798, 1991.
• Merrifield, “Solid Phase Synthesis,”Science, vol. 232, pp. 341-347, Apr. 18, 1986.
• Fields et al., “Solid Phase Peptide Synthesis Utilizing 9-Fluorenylmethoxycarbonyl Amino Acids,” Intl. J. Peptide Protein Res., vol. 35, pp. 161-214, 1990.
• Hampson et al., “Separation of Radiolabelled Glycosaminoglycan Oligosaccharides by Polyacrylamide-Gel Electrophoresis,” vol. 221, pp. 697-705, 1984.
• Farach-Carson et al., “Extraction and Isolation of Glycoproteins and Proteoglycans,” BioTechniques, vol. 7, No. 5, pp. 482-493, 1989.
• Hovingh et al., “Differentially Expressed Patterns of Glycosaminoglycan Structure in Heparan Sulfate Proteoglycans and Free Chains,” Eur. J. Biochem., vol. 211, pp. 771-779, 1993.